13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1(5094-14-4)
- Name: 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1
- Synonyms:Cyclopentaneheptanoicacid, 3-hydroxy-5-oxo-2-(3-oxooctyl)- (7CI); Cyclopentaneheptanoic acid,3-hydroxy-5-oxo-2-(3-oxooctyl)-, stereoisomer (8CI); 11a-Hydroxy-9,15-diketoprostanoicacid; 11a-Hydroxy-9,15-dioxoprostanoicacid; 13,14-Dihydro-15-keto-PGE1; 13,14-Dihydro-15-keto-PGE1;13,14-Dihydro-15-ketoprostaglandin E1; 13,14-Dihydro-15-oxo-PGE1;15-Oxodihydroprostaglandin E1; 15-keto-13,14-Dihydro-PGE1;15-keto-13,14-Dihydroprostaglandin E1; Dihydro-15-ketoprostaglandin E1; U 21002
- Molecular Formula:C20H34 O5
- Molecular Weight:354.487
- CAS Registry Number:5094-14-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.5094-14-4 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.5094-14-4 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.5094-14-4 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 132742-04-2/3-nitro-7,8-dihydrobenzo[pqr]tetraphene
- 7147-09-3/4-[(2-hydroxy-4-oxo-1,4-dihydroquinolin-3-yl)(methyl)amino]benzamide
- 13156-95-1/2-CHLORO-N-PHENETHYLACETAMIDE
- 60254-48-0/2-amino-N(6)-methoxyadenine
- 77502-27-3/Tolpadol
- 17123-21-6/2,5-dichloro-3,6-bis[(4-methoxyphenyl)amino]cyclohexa-2,5-diene-1,4-dione
- 165315-23-1/N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-{[2-(propan-2-yl)-1,3-thiazol-4-yl]acetyl}-L-valinamide
- 59138-54-4/4-[(4-nitrobenzoyl)oxy]phenyl 4-(hexyloxy)benzoate
- 17091-87-1/N-Acetyl-L-glutamic acid, compound with 5-hydroxy-6-methylpyridine-3,4-dimethanol
- 19224-26-1/1,2-PROPANEDIOL DIBENZOATE
- 1226-95-5/4-(4,4-dimethylpiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one
- 7496-87-9/1-phenyl-2-(2-propylpyridin-1(2H)-yl)ethanone
- 6811-77-4/3-deazaadenine
- 82058-33-1/N-ethyl-9-oxo-2,4,6,8-tetraphenyl-3,7-diazabicyclo[3.3.1]nonane-3-carbothioamide
- 64018-26-4/3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-henicosafluorododecanoyl chloride
- 53555-23-0/[N,N,N',N',N'',N''-hexamethyl-29H,31H-phthalocyaninetrimethylaminato(2-)-N29,N30,N31,N32]copper
- 5615-80-5/aspartimide
- 16637-56-2/1,2-Benzenediol,4-[(6,7-dimethoxy-1-isoquinolinyl)methyl]-
- 57152-96-2/(3S)-3-(methoxycarbonyl)-1-methyl-4-phenylpiperidinium bromide
- 5094-14-4/13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1
- 91261-12-0/insulin, Gln(B30)-
- 56832-47-4/angiotensin II, Sar(1)-Thr(8)-
- 85631-15-8/Alkenes, C8-10, hydroformylation products, distn. residues
- 78218-65-2/2-bis(dimethylamino)phosphinothioyl-5-methyl-1,2,4-triazol-3-amine
- 72811-84-8/Tulirinol
- 54340-88-4/2,3-Dihydro-1,5,7-trimethyl-1H-indene
- 6272-79-3/N-naphthalen-1-yl-1-[2-(N-naphthalen-1-ylcarbamimidoyl)sulfanylethylsulfanyl]methanimidamide
- 81827-55-6/2,5-Cyclohexadien-1-one, 2-benzoyl-4-(3,7-dimethyl-2,6-octadienyl)-3-h ydroxy-4,6-bis(3-methyl-2-butenyl)-
- 39004-41-6/6-(2-chloroethyl)-2,2,5,7-tetramethyl-2,3-dihydro-1H-inden-1-one
- 37102-74-2/3-Methylphthalate